Clinical trial
Application of Artificial Intelligence and Iron Metabolism Markers in Predicting ICU Outcomes for Critically Ill Cancer Patients
NCT07408661 is registered in ClinicalTrials.gov with Tongji University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Artificial Intelligence and Iron Metabolism Markers in Predicting ICU Outcomes for Critically Ill Cancer Patients
- Lead sponsor
- Tongji University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- December 1, 2025
- Enrollment
- 1,137 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cancer